Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Encouraging and Measuring Practice Improvements Via Sequential Continuing Âé¶¹´«Ã½Ó³»­
Research Methodology, Âé¶¹´«Ã½Ó³»­, and History
P7 - Poster Session 7 (5:30 PM-6:30 PM)
13-008
To deliver comprehensive continuing education (CE) with a reinforcing, decision-based CE case designed to measure and improve the care of patients living with MS. 
Given the rapid evolution regarding the understanding of MS immunopathology and recent clinical advances, neurology providers struggle to stay current on the latest evidence and how to apply it to practice.  While targeted CE is a suitable platform to address knowledge gaps, follow-up, case-based content can reinforce key educational concepts and facilitate performance change toward improved healthcare delivery. 

In 2018, Vindico Medical Âé¶¹´«Ã½Ó³»­ provided an immersive CE course designed to educate neurology professionals on critical advances regarding the care of people with MS, the proceedings of which were archived as a web-based CME activity. Thirty days later, completers of the program were directed to a decision-based clinical case for additional CE credit that was designed to reinforce content while promoting practice improvements. Participant practice patterns were assessed before and after both educational components, serving as a marker for practice change.

Overall, 426 neurology professionals completed one of the live or web-based CE sessions. Overall there was a 50% relative increase in knowledge because of participation in the CE. Of the 257 completers eligible to receive follow-up CE, 16% participated in the follow-up case for additional CE credit, doubling historical participation rates in non-accredited follow-up assessments. Of these, 79% would identify a patient with PPMS as a good candidate for anti-CD-20 therapy, a 37% improvement from pre-activity assessments. Moreover, of those who were not applying the latest criteria to identify patients with PPMS prior to the CME, 86% would do so in the realistic clinical scenario.

Incorporating sequential, decision-based clinical cases into traditional CE platforms is an impactful method to facilitate practice improvements while objectively measuring changes to practice toward improved healthcare delivery and patient health. 

Authors/Disclosures
Katie Robinson, PhD (Vindico Medical Âé¶¹´«Ã½Ó³»­)
PRESENTER
Dr. Robinson has nothing to disclose.
Jennifer Frederick Jennifer Frederick has nothing to disclose.
Jenna Gentile Jenna Gentile has nothing to disclose.
Robert Esgro No disclosure on file
Patricia K. Coyle, MD, FÂé¶¹´«Ã½Ó³»­ (SUNY At Stony Brook) Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.